BRCA2 and ovarian carcinoma: In the adult cancer literature, a study using data from The Cancer Genome Atlas on patients with ovarian cancer suggests that individuals with BRCA2 variants may have a better outcome due to higher sensitivity to chemotherapy compared with individuals with wild-type genotypes.27